arrow
S

Suning Chen

The First Affiliated Hospital of Soochow University
H指数:29
被引数:3,940

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhanced prognosis of acute myeloid leukaemia patients with dmCEBPAbZIP-inf mutations: Insights from a multicentre Chinese cohort study

携dm<sup>CEBPA</sup><sub>bZIP</sub><sup>-inf</sup>突变的急性髓系白血病患者的预后改善:一项多中心中国队列研究的启示

2026-09-050
PRE
Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter study

新诊断急性髓系白血病中具有高风险早期死亡特征的急粒单细胞白血病样亚组的临床与分子综合特征:一项多中心研究

2026-05-010
OA
Gilteritinib maintenance after allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute myeloid leukemia with FLT3-internal tandem duplication mutation

FLT3-内部串联重复突变阳性复发/难治性急性髓系白血病患者异基因造血干细胞移植后的Gilteritinib维持治疗

2025-12-310
PRE
IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial

IL-6基因敲低抗CD19 CAR-T细胞(ssCART-19)用于复发或难治性急性淋巴细胞白血病患者的I期临床试验

2025-10-270
OA
Epidemiology, Clinical Features, and Molecular Basis of TTMV::RARA-driven Acute Promyelocytic Leukemia

流行病学、临床特征及TTMV::RARA驱动的急性早幼粒细胞白血病的分子基础

Blood
IF23.1
2025-08-190
PRE
A novel truncated fusion gene ETV6::AC010198.2 in post-MPN acute myeloid leukemia caused by del(12)(p13p11)

del(12)(p13p11) 引起的MPN后急性髓系白血病中新的截短融合基因ETV6::AC010198.2

2025-02-110
OAAI
Ponatinib 2-Year Efficacy, Safety and Health-Related Quality of Life in Patients with Philadelphia Chromosome-Positive Leukemia: An Open-Label, Multicenter, Phase 2 Clinical Trial in China

Ponatinib 2年疗效、安全性和健康相关生活质量:中国一项开放标签、多中心、II期临床试验,用于费城染色体阳性白血病患者

BLOOD
IF23.1
2024-11-050
PRE